The ratios between all three NET markers and DNase1 antigen were also notably higher in the most severe patients (Fig. 3B–D), further supporting the idea of an impaired balance between DNase1 protein and NET markers in the most severe COVID-19 patients. This evidence concerns the gene DNASE1 and COVID-19.